Q1 2023 Sartorius AG and Sartorius Stedim Biotech SA Earnings Call Transcript
Good day, and welcome to the Sartorius and Sartorius Stedim Biotech Conference Call on the Q1, 2023 Results. Today's conference is being recorded.
At this time, it's my pleasure, and I would like to turn the conference over to Dr. Joachim Kreuzburg, CEO of Sartorius Group. Please go ahead, sir.
Thank you very much, and also welcome from our side to our today's conference call on the Q1 results for 2023 for Sartorius as well as for Sartorius Stedim Biotech. We will run the call slightly differently from the previous times. I will make the introduction, as always, then Rainer will walk you through the main results for the Sartorius Group as well as for the divisions.
And then Rene Faber, who is leading the Bioprocess Solutions Division at Sartorius since 4 years and now is also the CEO of Sartorius Stedim Biotech will then focus on the Sartorius Stedim Biotech's numbers. Therefore, we will also slightly shift the presentation between BPS and SSB. Usually, we
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |